FindTrial
Sign In

Tubeless Uniportal VATS Treat Clinical I Stage Non-Smoll Cell Lung Cancer: Single-center Clinical Controlled Trial

Tubeless Uniportal VATS Treat Clinical I Stage Non-Smoll Cell Lung Cancer: Single-center Clinical Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017854
Enrollment
Unknown
Registered
2018-08-17
Start date
2019-01-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

The Experiment Group:Tubeless
The Control group:Conventional intubation

Sponsors

Department of Thoracic Surgery, Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patient age 19–80 years old; 2. T1a stage(size<2cm) peripheral lung adenocarcinoma 3. ECOG 0-2 4. Postoperative survival was expected to be greater than or equal to 6 months 5. Compliance with research plans and other programme requirements 6. Volunteer and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Solid pulmonary nodules; 2. Central lung cancer; 3. Distant metastasis or hydrothorax; 4. Serious damage to heart, liver and kidney function; 5. Combined with other malignancies or hematopathy; 6. With distant metastasis or hydrothorax; 7. With obvious surgical contraindication.

Design outcomes

Primary

MeasureTime frame
postoperation complication;Hospital stay;surgery cost;postoperative pain;—

Secondary

MeasureTime frame
operative time;—

Countries

China

Contacts

Public ContactZheng Hui

Department of Thoracic Surgery, Shanghai Pulmonary Hospital, Tongji University School of Medicine

zh981117@126.com+86 13917866228

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026